Navidea Biopharmaceuticals to Present at BIO Investor Forum
October 14 2015 - 6:30AM
Business Wire
Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), announces
that Rick Gonzalez, President and Chief Executive Officer, will
present a corporate overview on Wednesday, October 21, 2015 at
11:30 AM PT at the 14th Annual BIO Investor Forum, taking place in
San Francisco, CA.
A live webcast of Mr. Gonzalez’s presentation can be accessed at
the following URL:
http://www.veracast.com/webcasts/bio/investorforum2015/98208295577.cfm.
An archived version of the webcast will be available two hours
following the presentation and can be accessed within the
Investors' section of the Navidea website at www.navidea.com.
About Navidea
Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) is a
biopharmaceutical company focused on the development and
commercialization of precision diagnostics, therapeutics and
radiopharmaceutical agents. Navidea is developing multiple
precision-targeted products and platforms including Manocept™ and
NAV4694 to help identify the sites and pathways of undetected
disease and enable better diagnostic accuracy, clinical
decision-making, targeted treatment and, ultimately, patient care.
Lymphoseek® (technetium Tc 99m tilmanocept) injection, Navidea’s
first commercial product from the Manocept platform, was approved
by the FDA in March 2013 and in Europe in November 2014. Navidea’s
strategy is to deliver superior growth and shareholder return by
bringing to market novel radiopharmaceutical agents and
therapeutics, and advancing the Company’s pipeline through global
partnering and commercialization efforts. For more information,
please visit www.navidea.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20151014005306/en/
Navidea BiopharmaceuticalsInvestorsTom Baker,
617-532-0624tbaker@navidea.comorMediaSharon Correia, 978-655-2686Associate
Director, Corporate Communications
Navidea Biopharmaceuticals (AMEX:NAVB)
Historical Stock Chart
From Apr 2024 to May 2024
Navidea Biopharmaceuticals (AMEX:NAVB)
Historical Stock Chart
From May 2023 to May 2024